Interleukin-7 Resensitizes Non-Small-Cell Lung Cancer to Cisplatin via Inhibition of ABCG2

Treatment with cisplatin (DDP) is one of the standard therapies used to treat non-small-cell lung cancer (NSCLC) and fundamentally causes resistance in cancer cells, which eventually poses as an obstacle to the efficacy of chemotherapy in NSCLC. Efforts are on all over the world to explore a sensiti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mediators Inflamm
Main Authors: Ke, Bin, Wei, Ting, Huang, Yuanyuan, Gong, Yuxin, Wu, Gang, Liu, Junfang, Chen, Xiaoting, Shi, Lin
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6931030/
https://ncbi.nlm.nih.gov/pubmed/31915416
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/7241418
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados